Study Methods (Part 2)
The second part of the study involved a comprehensive screening of a
wider range of TXA injection products collected from the E-MOTIVE
implementation sites in Kenya, Nigeria, South Africa and Tanzania.
Compatibility was assessed against two OXY injection products used at
the trial sites.